Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Flow Cytometric Detection of Malignant Blasts in Cerebrospinal Fluid: A Biomarker of Central Nervous System Involvement in Childhood Acute Lymphoblastic Leukemia

Publikation: Bidrag til tidsskriftReviewpeer review


  1. Passive Immunization in Alpha-Synuclein Preclinical Animal Models

    Publikation: Bidrag til tidsskriftReviewpeer review

  2. Concentration- and pH-Dependent Oligomerization of the Thrombin-Derived C-Terminal Peptide TCP-25

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Cord-Blood Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Vis graf over relationer

Despite the excellent prognosis for children and adolescents with acute lymphoblastic lymphoma (ALL), the involvement of the central nervous system (CNS) represents a major therapeutic challenge. Patients who develop CNS relapse have a very poor prognosis, and since current methods cannot reliably identify patients with CNS involvement or patients at high risk of CNS relapse, all children with ALL receive CNS-directed treatment. The current golden standard for detecting CNS involvement is the assessment of cytomorphology on cytospin slides of cerebrospinal fluid (CSF). This technique is inadequate due to low sensitivity and reproducibility. Flow cytometric analysis of CSF represent a novel, highly specific and sensitive technique for the detection of leukemic cells in the CNS. In prospective studies, CSF flow cytometry demonstrated two to three times higher rates of CNS involvement at diagnosis of childhood ALL than conventional cytospin, and especially demonstrated superior sensitivity in detecting low-level CNS disease. CNS involvement determined via flow cytometry has been linked to a higher risk of CNS relapse and poor outcomes in several studies. In this review, we discuss the central analytical concepts of CSF flow cytometry and summarize the current evidence supporting the use of flow cytometric detection of malignant blasts as a biomarker of CNS involvement in childhood ALL.

Udgave nummer6
StatusUdgivet - 9 jun. 2022

ID: 79006921